{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:28:40Z","timestamp":1793312920184,"version":"4.5.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T00:00:00Z","timestamp":1619740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T00:00:00Z","timestamp":1619740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1038\/s41401-021-00651-2","type":"journal-article","created":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T13:04:37Z","timestamp":1619787877000},"page":"2155-2172","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Pharmacokinetics-based identification of pseudoaldosterogenic compounds originating from Glycyrrhiza uralensis roots (Gancao) after dosing LianhuaQingwen capsule"],"prefix":"10.1038","volume":"42","author":[{"given":"Xiao-fang","family":"Lan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olajide E.","family":"Olaleye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-lan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei-fei","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-hong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-shan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan-nan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-wei","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-fei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nai-xia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-wei","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,30]]},"reference":[{"key":"651_CR1","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.apsb.2020.06.009","volume":"10","author":"L-Q Ni","year":"2020","unstructured":"Ni LQ, Chen LL, Huang X, Han CP, Xu JR, Zhang H, et al. Combating COVID-19 with integrated traditional Chinese and Western medicine in China. Acta Pharm Sin B. 2020;10:1149\u201362.","journal-title":"Acta Pharm Sin B."},{"key":"651_CR2","unstructured":"Chinese National Health Commission and State Administration of Traditional Chinese Medicine. Diagnosis and treatment protocol for novel coronavirus pneumonia (Trial Version 7), March 3, 2020. (https:\/\/www.who.int\/docs\/default-source\/wpro---documents\/countries\/china\/covid-19-briefing-nhc\/1-clinical-protocols-for-the-diagnosis-and-treatment-of-covid-19-v7.pdf?sfvrsn=c6cbfba4_2)."},{"key":"651_CR3","doi-asserted-by":"crossref","unstructured":"Hu K, Guan WJ, Bi Y, Zhang W, Li LJ, Zhang BL, et al. Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: a multicenter, prospective, randomized controlled trial. Phytomedicine. 2020;153242.","DOI":"10.1016\/j.phymed.2020.153242"},{"key":"651_CR4","first-page":"8","volume":"26","author":"K-T Yao","year":"2020","unstructured":"Yao KT, Liu YM, Li X, Huang JH, Cai HB. Retrospective clinical analysis on treatment of novel coronavirus infected pneumonia with traditional Chinese medicine Lianhua Qingwen. Chin J Exp Tradit Med Formula. 2020;26:8\u201312.","journal-title":"Chin J Exp Tradit Med Formula"},{"key":"651_CR5","first-page":"509","volume":"37","author":"D-Z Cheng","year":"2020","unstructured":"Cheng DZ, Wang WJ, Li Y, Wu XD, Zhou B, Song QY. Analysis of curative effect of 51 patients with novel coronavirus pneumonia treated with Chinese medicine Lianhua Qingwen: a multicentre retrospective study. Tianjin J Tradit Chin Med. 2020;37:509\u201315.","journal-title":"Tianjin J Tradit Chin Med"},{"key":"651_CR6","doi-asserted-by":"publisher","first-page":"104761","DOI":"10.1016\/j.phrs.2020.104761","volume":"156","author":"R-F Li","year":"2020","unstructured":"Li RF, Hou YL, Huang JC, Pan WQ, Ma QH, Shi YX, et al. Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2). Pharmacol Res. 2020;156:104761.","journal-title":"Pharmacol Res"},{"key":"651_CR7","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.apsb.2020.10.002","volume":"11","author":"X-F Chen","year":"2021","unstructured":"Chen XF, Wu YL, Chen C, Gu YQ, Zhu CY, Wang SP, et al. Identifying potential anti-COVID-19 pharmacological components of traditional Chinese medicine Lianhuaqingwen capsule based on human exposure and ACE2 biochromatography screening. Acta Pharm Sin B. 2021;11:222\u201336.","journal-title":"Acta Pharm Sin B"},{"key":"651_CR8","unstructured":"Chinese National Health Commission and Chinese State Administration of Traditional Chinese Medicine. Diagnosis and treatment plan for influenza (2019 version), November 7, 2019. (http:\/\/www.nhc.gov.cn\/yzygj\/s7653p\/201911\/a577415af4e5449cb30ecc6511e369c7\/files\/75a810713dc14dcd9e6db8b654bdef79.pdf)."},{"key":"651_CR9","first-page":"352","volume":"5","author":"National Health and Family Planning Commission of People\u2019s Republic of China.","year":"2015","unstructured":"National Health and Family Planning Commission of People\u2019s Republic of China. Gulideline on diagnosis and treatment of Middle East respirotory syndrome (2015 version). Chin J Viral Dis. 2015;5:352\u201354.","journal-title":"Chin J Viral Dis"},{"key":"651_CR10","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1124\/dmd.108.021592","volume":"36","author":"T Lu","year":"2008","unstructured":"Lu T, Yang JL, Gao XM, Chen P, Du FF, Sun Y, et al. Plasma and urinary tanshinol from Salvia miltiorrhiza (Danshen) can be used as pharmacokinetic markers for cardiotonic pills, a cardiovascular herbal medicine. Drug Metab Dispos. 2008;36:1578\u201386.","journal-title":"Drug Metab Dispos"},{"key":"651_CR11","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1124\/dmd.109.029819","volume":"37","author":"H-F Liu","year":"2009","unstructured":"Liu HF, Yang JL, Du FF, Gao XM, Ma XT, Huang YH, et al. Absorption and disposition of ginsenosides after oral administration of Panax notoginseng extract to rats. Drug Metab Dispos. 2009;37:2290\u20138.","journal-title":"Drug Metab Dispos"},{"key":"651_CR12","doi-asserted-by":"publisher","first-page":"494","DOI":"10.2174\/1389200211209050494","volume":"13","author":"L Li","year":"2012","unstructured":"Li L, Zhao YS, Du FF, Yang JL, Xu F, Niu W, et al. Intestinal absorption and presystemic elimination of various chemical constituents present in GBE50 extract, a standardized extract of Ginkgo biloba leaves. Curr Drug Metab. 2012;13:494\u2013509.","journal-title":"Curr Drug Metab"},{"key":"651_CR13","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/bph.12285","volume":"170","author":"F Chen","year":"2013","unstructured":"Chen F, Li L, Xu F, Sun Y, Du FF, Ma XT, et al. Systemic and cerebral exposure to and pharmacokinetics of flavonols and terpenelactones after dosing standardized Ginkgo biloba leaf extracts to rats via different routes of administration. Br J Pharmacol. 2013;170:440\u201357.","journal-title":"Br J Pharmacol"},{"key":"651_CR14","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1124\/dmd.113.051391","volume":"41","author":"Z-Y Hu","year":"2013","unstructured":"Hu ZY, Yang JL, Cheng C, Huang YH, Du FF, Wang FQ, et al. Combinatorial metabolism notably affects human systemic exposure to ginsenosides from orally administered extract of Panax notoginseng roots (Sanqi). Drug Metab Dispos. 2013;41:1457\u201369.","journal-title":"Drug Metab Dispos"},{"key":"651_CR15","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1124\/dmd.114.061473","volume":"43","author":"M-J Li","year":"2015","unstructured":"Li MJ, Wang FQ, Huang YH, Du FF, Zhong CC, Olaleye OE, et al. Systemic exposure to and disposition of catechols derived from Salvia miltiorrhiza roots (Danshen) after intravenous dosing DanHong injection in human subjects, rats, and dogs. Drug Metab Dispos. 2015;43:679\u201390.","journal-title":"Drug Metab Dispos"},{"key":"651_CR16","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1124\/dmd.116.071647","volume":"44","author":"C Cheng","year":"2016","unstructured":"Cheng C, Du F, Yu K, Xu F, Wang FQ, Li L, et al. Pharmacokinetics and disposition of circulating iridoids and organic acids in rats intravenously receiving ReDuNing injection. Drug Metab Dispos. 2016;44:1853\u20138.","journal-title":"Drug Metab Dispos"},{"key":"651_CR17","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/aps.2015.103","volume":"37","author":"C Cheng","year":"2016","unstructured":"Cheng C, Lin JZ, Li L, Yang JL, Jia WW, Huang YH, et al. Pharmacokinetics and disposition of monoterpene glycosides derived from Paeonia lactiflora roots (Chishao) after intravenous dosing of antiseptic XueBiJing injection in human subjects and rats. Acta Pharmacol Sin. 2016;37:530\u201344.","journal-title":"Acta Pharmacol Sin"},{"key":"651_CR18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.dmpk.2015.10.005","volume":"31","author":"X-X Li","year":"2016","unstructured":"Li XX, Cheng C, Wang FQ, Huang YH, Jia WW, Olaleye OE, et al. Pharmacokinetics of catechols in human subjects intravenously receiving XueBiJing injection, an emerging antiseptic herbal medicine. Drug Metab Pharmacokinet. 2016;31:95\u20138.","journal-title":"Drug Metab Pharmacokinet"},{"key":"651_CR19","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1124\/dmd.117.079673","volume":"46","author":"N-T Zhang","year":"2018","unstructured":"Zhang NT, Cheng C, Olaleye OE, Sun Y, Li L, Huang YH, et al. Pharmacokinetics-based identification of potential therapeutic phthalides from XueBiJing, a Chinese herbal injection used in sepsis management. Drug Metab Dispos. 2018;46:823\u201334.","journal-title":"Drug Metab Dispos"},{"key":"651_CR20","doi-asserted-by":"publisher","first-page":"112658","DOI":"10.1016\/j.jep.2020.112658","volume":"253","author":"H-Y Zhang","year":"2020","unstructured":"Zhang HY, Niu W, Olaleye OE, Du FF, Wang FQ, Huang YH, et al. Comparison of intramuscular and intravenous pharmacokinetics of ginsenosides in humans after dosing XueShuanTong, a lyophilized extract of Panax notoginseng roots. J Ethnopharmacol. 2020;253:112658.","journal-title":"J Ethnopharmacol"},{"key":"651_CR21","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1038\/s41401-018-0086-7","volume":"39","author":"X-W Liu","year":"2018","unstructured":"Liu XW, Yang JL, Niu W, Jia WW, Olaleye OE, Wen Q, et al. Human pharmacokinetics of ginkgo terpene lactones and impact of carboxylation in blood on their platelet-activating factor antagonistic activity. Acta Pharmacol Sin. 2018;39:1935\u201346.","journal-title":"Acta Pharmacol Sin"},{"key":"651_CR22","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/cpt.784","volume":"103","author":"G-X Xie","year":"2018","unstructured":"Xie GX, Wang SL, Zhang H, Zhao AH, Liu JJ, Ma YM, et al. Poly-pharmacokinetic study of a multicomponent herbal medicine in healthy Chinese volunteers. Clin Pharmacol Ther. 2018;103:692\u2013702.","journal-title":"Clin Pharmacol Ther"},{"key":"651_CR23","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/s41401-018-0173-9","volume":"40","author":"OE Olaleye","year":"2019","unstructured":"Olaleye OE, Niu W, Du FF, Wang FQ, Xu F, Pintusophon S, et al. Multiple circulating saponins from intravenous ShenMai inhibit OATP1Bs in vitro: potential joint precipitants of drug interactions. Acta Pharmacol Sin. 2019;40:833\u201349.","journal-title":"Acta Pharmacol Sin"},{"key":"651_CR24","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/s41401-019-0273-1","volume":"40","author":"S Pintusophon","year":"2019","unstructured":"Pintusophon S, Niu W, Duan XN, Olaleye OE, Huang YH, Wang FQ, et al. Intravenous formulation of Panax notoginseng root extract: human pharmacokinetics of ginsenosides and potential for perpetrating drug interactions. Acta Pharmacol Sin. 2019;40:1351\u201363.","journal-title":"Acta Pharmacol Sin"},{"key":"651_CR25","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.apsb.2019.06.003","volume":"9","author":"J Li","year":"2019","unstructured":"Li J, Olaleye OE, Yu X, Jia WW, Yang JL, Lu C, et al. High degree of pharmacokinetic compatibility exists between the five-herb medicine XueBiJing and antibiotics comedicated in sepsis care. Acta Pharm Sin B. 2019;9:1035\u201349.","journal-title":"Acta Pharm Sin B"},{"key":"651_CR26","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1056\/NEJMra1600266","volume":"375","author":"SV Lynch","year":"2016","unstructured":"Lynch SV, Pedersen O. The human intestinal microbiome in health and disease. N Engl J Med. 2016;375:2369\u201379.","journal-title":"N Engl J Med"},{"key":"651_CR27","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.3389\/fimmu.2018.02640","volume":"9","author":"S Hanada","year":"2018","unstructured":"Hanada S, Pirzadeh M, Carver KY, Deng JC. Respiratory viral infection-induced microbiome alterations and secondary bacterial pneumonia. Front Immunol. 2018;9:2640.","journal-title":"Front Immunol"},{"key":"651_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.trsl.2020.08.004","volume":"226","author":"S Villapol","year":"2020","unstructured":"Villapol S. Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome. Transl Res. 2020;226:57\u201369.","journal-title":"Transl Res"},{"key":"651_CR29","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/1751-2980.12851","volume":"21","author":"Q-Y Gao","year":"2020","unstructured":"Gao QY, Chen YX, Fang JY. 2019 Novel coronavirus infection and gastrointestinal tract. J Dig Dis. 2020;21:125\u20136.","journal-title":"J Dig Dis"},{"key":"651_CR30","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1016\/S0140-6736(03)13615-X","volume":"361","author":"J Cinatl","year":"2003","unstructured":"Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr HW. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet. 2003;361:2045\u20136.","journal-title":"Lancet"},{"key":"651_CR31","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1177\/2042018812454322","volume":"3","author":"HR Omar","year":"2012","unstructured":"Omar HR, Komarova I, El-Ghonemi M, Fathy A, Rashad R, Abdelmalak HD, et al. Licorice abuse: time to send a warning message. Ther Adv Endocrinol Metab. 2012;3:125\u201338.","journal-title":"Ther Adv Endocrinol Metab"},{"key":"651_CR32","first-page":"1929","volume":"80","author":"H Kato","year":"1995","unstructured":"Kato H, Kanaoka M, Yano S, Kobayashi M. 3-Monoglucuronyl-glycyrrhetinic acid is a major metabolite that causes licorice-induced pseudoaldosteronism. J Clin Endocrinol Metab. 1995;80:1929\u201333.","journal-title":"J Clin Endocrinol Metab"},{"key":"651_CR33","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.lfs.2007.01.033","volume":"80","author":"N Ohtake","year":"2007","unstructured":"Ohtake N, Kido A, Kubota K, Tsuchiya N, Morita T, Kase Y, et al. A possible involvement of 3-monoglucuronyl-glycyrrhetinic acid, a metabolite of glycyrrhizin (GL), in GL-induced pseudoaldosteronism. Life Sci. 2007;80:1545\u201352.","journal-title":"Life Sci"},{"key":"651_CR34","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1124\/dmd.108.021089","volume":"36","author":"T Makino","year":"2008","unstructured":"Makino T, Ohtake N, Watanabe A, Tsuchiya N, Imamura S, Iizuka S, et al. Down-regulation of a hepatic transporter multidrug resistance-associated protein 2 is involved in alteration of pharmacokinetics of glycyrrhizin and its metabolites in a rat model of chronic liver injury. Drug Metab Dispos. 2008;36:1438\u201343.","journal-title":"Drug Metab Dispos"},{"key":"651_CR35","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1124\/jpet.111.190009","volume":"342","author":"T Makino","year":"2012","unstructured":"Makino T, Okajima K, Uebayashi R, Ohtake N, Inoue K, Mizukami H. 3-Monoglucuronyl-glycyrrhretinic acid is a substrate of organic anion transporters expressed in tubular epithelial cells and plays important roles in licorice-induced pseudoaldosteronism by inhibiting 11\u03b2-hydroxysteroid dehydrogenase 2. J Pharmacol Exp Ther. 2012;342:297\u2013304.","journal-title":"J Pharmacol Exp Ther"},{"key":"651_CR36","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1248\/bpb.b13-00997","volume":"37","author":"T Makino","year":"2014","unstructured":"Makino T. 3-Monoglucuronyl glycyrrhretinic acid is a possible marker compound related to licorice-induced pseudoaldosteronism. Biol Pharm Bull. 2014;37:898\u2013902.","journal-title":"Biol Pharm Bull"},{"key":"651_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-38182-2","volume":"9","author":"K Ishiuchi","year":"2019","unstructured":"Ishiuchi K, Morinaga O, Ohkita T, Tian C-T, Hirasawa A, Mitamur M, et al. 18\u03b2-Glycyrrhetyl-3-O-sulfate would be a causative agent of licorice-induced pseudoaldosteronism. Sci Rep. 2019;9:1587.","journal-title":"Sci Rep."},{"key":"651_CR38","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.1007\/s00204-019-02588-2","volume":"93","author":"K Takahashi","year":"2019","unstructured":"Takahashi K, Yoshino T, Maki Y, Ishiuchi K, Namiki T, Ogawa-Ochiai K, et al. Identification of glycyrrhizin metabolites in humans and of a potential biomarker of liquorice-induced pseudoaldosteronism: a multi-centre cross-sectional study. Arch Toxicol. 2019;93:3111\u20139.","journal-title":"Arch Toxicol"},{"key":"651_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-33834-9","volume":"8","author":"O Morinaga","year":"2018","unstructured":"Morinaga O, Ishiuchi K, Ohkita T, Tian CT, Hirasawa A, Mitamur M, et al. Isolation of a novel glycyrrhizin metabolite as a causal candidate compound for pseudoaldosteronism. Sci Rep. 2018;8:15568.","journal-title":"Sci Rep."},{"key":"651_CR40","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1124\/dmd.115.064477","volume":"43","author":"C McCabe","year":"2015","unstructured":"McCabe C, Sane RS, Keith-Luzzi M, Xu J, King I, Whitcher-Johnstone A, et al. Defining the role of gut bacteria in the metabolism of deleobuvir: in vitro and in vivo studies. Drug Metab Dispos. 2015;43:1612\u20138.","journal-title":"Drug Metab Dispos"},{"key":"651_CR41","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1365-2125.2011.04076.x","volume":"73","author":"J-L Yang","year":"2012","unstructured":"Yang J-L, He M-M, Niu W, Wrighton SA, Li L, Liu Y, et al. Metabolic capabilities of cytochrome P450 enzymes in Chinese liver microsomes compared with those in Caucasian liver microsomes. Br J Clin Pharmacol. 2012;73:268\u201384.","journal-title":"Br J Clin Pharmacol"},{"key":"651_CR42","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/aps.2015.20","volume":"36","author":"D-D Tian","year":"2015","unstructured":"Tian DD, Jia WW, Liu XW, Wang DD, Liu JH, Dong JJ, et al. Methylation and its role in the disposition of tanshinol, a cardiovascular carboxylic catechol from Salvia miltiorrhiza roots (Danshen). Acta Pharmacol Sin. 2015;36:627\u201343.","journal-title":"Acta Pharmacol Sin"},{"key":"651_CR43","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1124\/dmd.114.062000","volume":"43","author":"W-W Jia","year":"2015","unstructured":"Jia WW, Du FF, Liu XW, Jiang RR, Xu F, Yang JL, et al. Renal tubular secretion of tanshinol: molecular mechanisms, impact on its systemic exposure, and propensity for dose-related nephrotoxicity and for renal herb-drug interactions. Drug Metab Dispos. 2015;43:669\u201378.","journal-title":"Drug Metab Dispos"},{"key":"651_CR44","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.1111\/bph.14393","volume":"175","author":"J-J Dong","year":"2018","unstructured":"Dong JJ, Olaleye OE, Jiang RR, Li J, Lu C, Du FF, et al. Glycyrrhizin has a high likelihood to be a victim of drug-drug interactions mediated by hepatic organic anion-transporting polypeptide 1B1\/1B3. Br J Pharmacol. 2018;175:3486\u2013503.","journal-title":"Br J Pharmacol"},{"key":"651_CR45","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/rcm.2265","volume":"20","author":"B Guo","year":"2006","unstructured":"Guo B, Li C, Wang G-J, Chen L-S. Rapid and direct measurement of free concentrations of highly protein-bound fluoxetine and its metabolite norfluoxetine in plasma. Rapid Commun Mass Spectrom. 2006;20:39\u201347.","journal-title":"Rapid Commun Mass Spectrom"},{"key":"651_CR46","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","volume":"22","author":"S Reagan-Shaw","year":"2008","unstructured":"Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 2008;22:659\u201361.","journal-title":"FASEB J"},{"key":"651_CR47","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1042\/bj3131007","volume":"313","author":"RW Brown","year":"1996","unstructured":"Brown RW, Chapman KE, Kotelevtsev Y, Yau JL, Lindsay RS, Brett L, et al. Cloning and production of antisera to human placental 11\u03b2-hydroxysteroid dehydrogenase type 2. Biochem J. 1996;313:1007\u201317.","journal-title":"Biochem J"},{"key":"651_CR48","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1023\/A:1018943613122","volume":"10","author":"B Davies","year":"1993","unstructured":"Davies B, Morris T. Physiological parameters in laboratory animals and humans. Pharmacol Res. 1993;10:1093\u20135.","journal-title":"Pharmacol Res"},{"key":"651_CR49","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nrd2505","volume":"7","author":"W Jia","year":"2008","unstructured":"Jia W, Li H, Zhao L-P, Nicholson KJ. Gut microbiota: a potential new territory for drug targeting. Nat Rev Drug Discov. 2008;7:123\u20139.","journal-title":"Nat Rev Drug Discov"},{"key":"651_CR50","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.pharmthera.2011.01.012","volume":"130","author":"PD Cani","year":"2011","unstructured":"Cani PD, Delzenne NM. The gut microbiome as therapeutic target. Pharmacol Ther. 2011;130:202\u201312.","journal-title":"Pharmacol Ther"},{"key":"651_CR51","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/ics.12548","volume":"41","author":"A Kowalska","year":"2019","unstructured":"Kowalska A, Kalinowska-Lis U. 18\u03b2-Glycyrrhetinic acid: its core biological properties and dermatological applications. Int J Cosmet Sci. 2019;41:325\u201331.","journal-title":"Int J Cosmet Sci"},{"key":"651_CR52","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3389\/fnagi.2018.00348","volume":"10","author":"M Ramalingam","year":"2018","unstructured":"Ramalingam M, Kim H, Lee Y, Lee YI. Phytochemical and pharmacological role of Liquiritigenin and isoliquiritigenin from radix glycyrrhizae in human health and disease models. Front Aging Neurosci. 2018;10:348.","journal-title":"Front Aging Neurosci"},{"key":"651_CR53","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1016\/j.chroma.2008.07.072","volume":"1216","author":"Q Zhang","year":"2009","unstructured":"Zhang Q, Ye M. Chemical analysis of the Chinese herbal medicine Gan-Cao (licorice). J Chromatogr A. 2009;1216:1954\u201369.","journal-title":"J Chromatogr A"},{"key":"651_CR54","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.chroma.2015.05.006","volume":"1402","author":"X Qiao","year":"2015","unstructured":"Qiao X, Song W, Ji S, Wang Q, Guo D-A, Ye M. Separation and characterization of phenolic compounds and triterpenoid saponins in licorice (Glycyrrhiza uralensis) using mobile phase-dependent reversed-phase \u00d7 reversed-phase comprehensive two-dimensional liquid chromatography coupled with mass spectrometry. J Chromatogr A. 2015;1402:36\u201345.","journal-title":"J Chromatogr A"},{"key":"651_CR55","doi-asserted-by":"publisher","first-page":"577","DOI":"10.2174\/1389200211209050577","volume":"13","author":"K Yu","year":"2012","unstructured":"Yu K, Chen F, Li C. Absorption, disposition, and pharmacokinetics of saponins from Chinese medicinal herbs: what do we know and what do we need to know more?. Curr Drug Metab. 2012;13:577\u201398.","journal-title":"Curr Drug Metab"},{"key":"651_CR56","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1152\/physrev.00020.2012","volume":"93","author":"K Chapman","year":"2013","unstructured":"Chapman K, Holmes M, Seckl J. 11\u03b2-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action. Physiol Rev. 2013;93:1139\u2013206.","journal-title":"Physiol Rev"},{"key":"651_CR57","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.coph.2015.01.005","volume":"21","author":"RW Hunter","year":"2015","unstructured":"Hunter RW, Bailey MA. Glucocorticoids and 11\u03b2-hydroxysteroid dehydrogenases: mechanisms for hypertension. Curr Opin Pharmacol. 2015;21:105\u201314.","journal-title":"Curr Opin Pharmacol"},{"key":"651_CR58","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1146\/annurev-pharmtox-011112-140317","volume":"53","author":"KM Morrissey","year":"2013","unstructured":"Morrissey KM, Stocker SL, Wittwer MB, Xu L, Giacomini KM. Renal transporters in drug development. Annu Rev Pharmacol Toxicol. 2013;53:503\u201329.","journal-title":"Annu Rev Pharmacol Toxicol."},{"key":"651_CR59","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.bcp.2017.01.010","volume":"130","author":"KR Beck","year":"2017","unstructured":"Beck KR, B\u00e4chler M, Vuorinen A, Wagner S, Akram M, Griesser U, et al. Inhibition of 11\u03b2-hydroxysteroid dehydrogenase 2 by the fungicides itraconazole and posaconazole. Biochem Pharmacol. 2017;130:93\u2013103.","journal-title":"Biochem Pharmacol"},{"key":"651_CR60","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jsbmb.2010.12.019","volume":"125","author":"DV Kratschmar","year":"2011","unstructured":"Kratschmar DV, Vuorinen A, Cunha TD, Wolber G, Classen-Houben D, Doblhoff O, et al. Characterization of activity and binding mode of glycyrrhetinic acid derivatives inhibiting 11\u03b2-hydroxysteroid dehydrogenase type 2. J Steroid Biochem Mol Biol. 2011;125:129\u201342.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"651_CR61","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nature25979","volume":"555","author":"L Maier","year":"2018","unstructured":"Maier L, Pruteanu M, Kuhn M, Zeller G, Telzerow A, Anderson EE, et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature. 2018;555:623\u20138.","journal-title":"Nature"},{"key":"651_CR62","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1126\/science.aau5812","volume":"362","author":"CL Gentile","year":"2018","unstructured":"Gentile CL, Weir TL. The gut microbiota at the intersection of diet and human health. Science. 2018;362:776\u201380.","journal-title":"Science"},{"key":"651_CR63","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41401-018-0011-0","volume":"40","author":"M Liu","year":"2019","unstructured":"Liu M, Yuan J, Hu WJ, Ke CQ, Zhang YF, Yang YE, et al. Pretreatment with broad-spectrum antibiotics alters the pharmacokinetics of major constituents of Shaoyao-Gancao decoction in rats after oral administration. Acta Pharmacol Sin. 2019;40:288\u201396.","journal-title":"Acta Pharmacol Sin"},{"key":"651_CR64","doi-asserted-by":"publisher","first-page":"S193","DOI":"10.1007\/s11739-012-0802-0","volume":"7","author":"A Gatta","year":"2012","unstructured":"Gatta A, Verardo A, Bolognesi M. Hypoalbuminemia. Intern Emerg Med. 2012;7:S193\u20139.","journal-title":"Intern Emerg Med"},{"key":"651_CR65","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ajic.2020.06.213","volume":"49","author":"KT Bajgain","year":"2021","unstructured":"Bajgain KT, Badal S, Bajgain BB, Santana MJ. Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature. Am J Infect Control. 2021;49:238\u201346.","journal-title":"Am J Infect Control"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-021-00651-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-021-00651-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-021-00651-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T08:00:31Z","timestamp":1744185631000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-021-00651-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,30]]},"references-count":65,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["651"],"URL":"https:\/\/doi.org\/10.1038\/s41401-021-00651-2","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,30]]},"assertion":[{"value":"18 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}